ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alegre, J.
Right arrow Articles by Fernández de Sevilla, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alegre, J.
Right arrow Articles by Fernández de Sevilla, T.
Eur Respir J 2002; 19:320-325
Copyright ©ERS Journals Ltd 2002


Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions

J. Alegre1, J. Jufresa1, R. Segura2, A. Ferrer3, L. Armadans4, C. Aleman1, R. Marti2, E. Ruiz1 and T. Fernández de Sevilla1

Depts of 1 Internal Medicine, 2 Biochemistry, 3 Microbiology, 4 Preventive Medicine and Epidemiology, Vall d'Hebron General Hospital, Barcelona, Spain

CORRESPONDENCE: J. Alegre, Juan de Garay 19, 3° 1a, 08041, Barcelona, Spain. Fax: 34 32844234. E-mail: 18502jam@comb.es

Keywords: myeloperoxidase, parapneumonic pleural effusions

Received: June 13, 2000
Accepted September 5, 2001

This work was financed in part by a Fondo de Investigacion Sanitaria grant (96/0977).

The diagnostic accuracy of myeloperoxidase (MPO) in pleural fluid, for differentiating between complicated and noncomplicated parapneumonic pleural effusions (PPE) evaluated prospectively.

Seventy patients aged >18 yrs with PPE (36 complicated and 34 noncomplicated) were studied after admission to a tertiary referral teaching hospital. MPO concentration was measured in plasma and pleural fluid using a double-antibody competitive radioimmunoassay.

The concentrations of MPO in complicated and noncomplicated PPE were compared using a Mann-Whitney U-test and multiple logistic regression models were used to predict the odds that an effusion was complicated. MPO pleural-fluid concentrations were significantly higher in complicated than in noncomplicated PPE. After excluding purulent effusions, pleural-fluid MPO was the marker that best differentiated between the two types of PPE: the area under the receiver operating characteristic curve was 0.912, the sensitivity was 87.5% and the specificity was 85.1% at a cut-point limit of 3.000 µg·L–1.

The authors concluded that the concentration of pleural-fluid myeloperoxidase helps to differentiate between nonpurulent complicated and noncomplicated parapneumonic pleural effusions.




This article has been cited by other articles:


Home page
ChestHome page
J. M. Porcel, M. Vives, and A. Esquerda
Tumor Necrosis Factor-{alpha} in Pleural Fluid: A Marker of Complicated Parapneumonic Effusions
Chest, January 1, 2004; 125(1): 160 - 164.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the European Respiratory Society.